Publikationen: Search
Now showing items 1-1 of 1
Irreversible Antagonists for the Adenosine A2B Receptor
(2022-06-13)
Blockade of the adenosine A2B receptor (A2BAR) represents a potential novel strategy for the immunotherapy of cancer. In the present study, we designed, synthesized, and characterized irreversible A2BAR antagonists based ...